Tandem Diabetes Care, Inc. (TNDM)

Tandem Diabetes Care Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	62.82	90.63	69.23	58.87	172.52	71.18
Short-Term Investments	393.18	202.03	369.1	409.04	444.38	552.63
Cash & Short-Term Investments	456	292.67	438.33	467.91	616.9	623.81
Cash Growth	44.59%	-33.23%	-6.32%	-24.15%	-1.11%	28.64%
Receivables	162.07	165.49	114.59	105.56	114.72	110.73
Inventory	135.11	128.77	149.61	157.94	111.12	68.55
Prepaid Expenses	51.47	31.22	21.97	16.59	7.24	8.43
Total Current Assets	804.64	618.14	724.49	747.99	849.98	811.52
Property, Plant & Equipment	184.69	179.75	163.46	164.33	179.18	77.89
Long-Term Investments	132.27	60.35	74.55	10.1	16.4	-
Other Intangible Assets	-	11.72	0.93	2.78	4.63	6.64
Other Long-Term Assets	32.61	11.15	4.24	27.46	2.6	9.09
Total Assets	1,154	881.11	967.66	952.66	1,053	905.14

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	64.13	47.07	44.73	49.59	55.73	28.03
Accrued Expenses	78.8	99.02	84.53	56.66	48.28	60.98
Current Portion of Long-Term Debt	-	4.9	45.47	-	-	-
Current Portion of Leases	20.27	19.47	18.21	17.06	13.12	9.28
Current Unearned Revenue	8.43	9.53	11.83	43.99	18.84	10.18
Other Current Liabilities	81.38	62.74	42.28	27.96	29.33	23.39
Total Current Liabilities	253.01	242.72	247.05	195.26	165.29	131.86
Long-Term Debt	602.58	310.04	308.27	289.74	287.93	281.47
Long-Term Leases	116.41	114.97	106.42	113.57	123.52	23.92
Long-Term Unearned Revenue	7.78	8.47	10.46	13.33	16.87	16.94
Other Long-Term Liabilities	44.05	49.74	32.37	27.13	19.22	17.84
Total Liabilities	1,024	725.94	704.56	639.03	612.84	472.03

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.07	0.07	0.07	0.07	0.07	0.06
Additional Paid-In Capital	1,418	1,402	1,313	1,264	1,171	1,068
Retained Earnings	-1,294	-1,253	-1,048	-951.8	-729.19	-634.6
Comprehensive Income & Other	6.4	5.59	-1.95	1.37	-1.82	-0.62
Shareholders' Equity	130.39	155.17	263.1	313.63	439.95	433.11
Total Liabilities & Equity	1,154	881.11	967.66	952.66	1,053	905.14

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	739.25	449.38	478.37	420.37	424.58	314.67
Net Cash (Debt)	-283.26	-156.71	-40.04	47.55	192.32	309.14
Net Cash Growth	-	-	-	-75.28%	-37.79%	20.47%
Net Cash Per Share	-4.15	-2.33	-0.61	0.73	3.00	4.80
Filing Date Shares Outstanding	69.58	68.33	66.47	65.63	64.53	63.87
Total Common Shares Outstanding	69.54	68.29	66.26	65.55	64.51	63.83
Working Capital	551.63	375.42	477.44	552.73	684.69	679.66
Book Value Per Share	1.88	2.27	3.97	4.78	6.82	6.79
Tangible Book Value	130.39	143.45	262.17	310.86	435.32	426.48
Tangible Book Value Per Share	1.88	2.10	3.96	4.74	6.75	6.68
Machinery	-	116.5	103.87	91.77	88.9	74.31
Leasehold Improvements	-	40.13	37.11	37.57	35.83	25.25

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error